Form 4: Director Richard Nottenburg Receives 200k Share Grant

Director Richard Nottenburg was granted 200,000 restricted shares of ChronoScale Corp common stock vesting over two years.

Summary

• Director Richard N. Nottenburg acquired 200,000 shares of common stock in ChronoScale Corp.
• The shares were granted as restricted stock on May 14, 2026.
• Vesting occurs in two equal tranches: 100,000 shares on May 14, 2027, and 100,000 shares on May 14, 2028.
• Vesting is contingent upon the director's continuous service to the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation, which does not signal immediate operational changes.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and issuance of these shares.

Risks

• Vesting is subject to continuous service requirements, which could be impacted by changes in board composition.

Future Outlook

The grant indicates a commitment to long-term board retention through multi-year vesting schedules.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a standard corporate governance practice designed to incentivize long-term strategic oversight and alignment with shareholder interests.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with multi-year vesting is consistent with standard executive and director compensation packages in the technology and growth sectors.

Stakeholder Impact

• Shareholders may experience minor dilution upon the vesting of these shares.

Next Steps

• Vesting of 100,000 shares on May 14, 2027.
• Vesting of 100,000 shares on May 14, 2028.

Key Dates

Keywords

ChronoScale, CHRN, Form 4, Insider Trading, Director Compensation, Equity Grant